According to an internal analysis, 29.6% of studies that are highly likely to fall under mandatory reporting requirements have no results information submitted to ClinicalTrials.gov.

FAST EU is directed to Facilitating and accelerating strategic clinical trials in the EU

Spain, France, Germany, Italy and Poland have access to the largest numbers of drug trials.

Ten Guiding Principles of Good AI Practice in Drug Development is mentioned in the guidance

According to the report EMA recommended 104 medicines in 2025 and 38 had a new active substance. Also 16 medicines were approved for rare diseases including the first drug for Wiscott-ALdrich syndrome.